Early recurrence after hepatectomy for colorectal liver metastases: What optimal definition and what predictive factors?

Oncologist

Volumn 21, Issue 7, 2016, Pages 887-894

  Imai, Katsunori ^a,b,e   Allard, Marc Antoine ^a,b,d   Benitez, Carlos Castro ^a,b,d   Vibert, Eric ^a,c,d   Sa Cunha, Antonio ^a,b,d   Cherqui, Daniel ^a,c,d   Castaing, Denis ^a,c,d   Bismuth, Henri ^a   Baba, Hideo ^e   Adam, René ^a,b,d  

^a HÔPITAL PAUL BROUSSE   (France)

^b INSERM   (France)

^c Universite Paris Sud   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Colorectal liver metastasis; Early recurrence; Hepatectomy; Minimum p value approach; Salvage surgery

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; PANITUMUMAB;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE FREE SURVIVAL; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER FUNCTION TEST; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; RECURRENCE RISK; SALVAGE THERAPY; SURVIVAL RATE; TUMOR VOLUME; VERY ELDERLY; COLORECTAL TUMOR; ETIOLOGY; LIVER NEOPLASMS; MORTALITY; PATHOLOGY; PROGNOSIS; SECONDARY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SALVAGE THERAPY;

EID: 84978485228     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2015-0468     Document Type: Article

References (31)

1. Simmonds PC, Primrose JN, Colquitt JL et al. Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 2006;94: 982-999.
2. Morris EJ, Forman D, Thomas JD et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 2010;97: 1110-1118.
3. Adam R, De Gramont A, Figueras J et al. The oncosurgery approach to managing liver metastases from colorectal cancer: A multidisciplinary internationalconsensus. TheOncologist 2012;17: 1225-1239.
4. Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235: 759-766.
5. de Jong MC, Pulitano C, RiberoDet al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: An international multi-institutional analysis of 1669 patients. Ann Surg 2009;250: 440-448.
6. D’Angelica M, Kornprat P, GonenMet al. Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Ann Surg Oncol 2011;18: 1096-1103.
7. Tomlinson JS, Jarnagin WR, DeMatteo RP et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007;25: 4575-4580.
8. Takahashi S, Konishi M, Nakagohri T et al. Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. Jpn J Clin Oncol 2006;36: 368-375.
9. Malik HZ, Gomez D,Wong V et al. Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur J Surg Oncol 2007;33: 1003-1009.
10. Yamashita Y, Adachi E, Toh Y et al. Risk factors for early recurrence after curative hepatectomy for colorectal livermetastases. Surg Today 2011;41: 526-532.
11. Kaibori M, Iwamoto Y, Ishizaki M et al. Predictors and outcome of early recurrence after resection of hepatic metastases from colorectal cancer. Langenbecks Arch Surg 2012;397: 373-381.
12. Tan MC, Butte JM, Gonen M et al. Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. HPB (Oxford) 2013;15: 803-813.
13. Takahashi S, Konishi M, Kinoshita T et al. Predictors for early recurrence after hepatectomy for initially unresectable colorectal liver metastasis. J Gastrointest Surg 2013;17: 939-948.
14. Viganó L, Capussotti L, Lapointe R et al. Early recurrence after liver resection for colorectal metastases: Risk factors, prognosis, and treatmen. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol 2014;21: 1276-1286.
15. Narita M, Oussoultzoglou E, Chenard MP et al. Predicting early intrahepatic recurrence after curative resection of colorectal livermetastaseswithmolecular markers. World J Surg 2015; 39: 1167-1176.
16. Adam R, de Haas RJ, Wicherts DA et al. Concomitant extrahepatic disease in patients with colorectal livermetastases: Whenis there a place for surgery? Ann Surg 2011;253: 349-359.
17. World Health Organization. Handbook for reporting results ofcancer treatment. WHOoffsetpublication no. 48. Geneva: World Health Organization, 1979.
18. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer,NationalCancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92: 205-216.
19. de Haas RJ, Wicherts DA, Flores E et al. R1 resection by necessity for colorectal livermetastases: Is it still a contraindicationto surgery? Ann Surg 2008; 248: 626-637.
20. Wicherts DA, de Haas RJ, Andreani P et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 2010;97: 240-250.
21. Adam R, Miller R, Pitombo M et al. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin NAm 2007;16: 525-536, viii.
22. Wicherts DA, Miller R, de Haas RJ et al. Longterm results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 2008;248: 994-1005.
23. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240: 205-213.
24. Steele SR, Park GE, Johnson EK et al.The impact of age on colorectal cancer incidence, treatment, and outcomes in an equal-access health care system. Dis Colon Rectum 2014;57: 303-310.
25. You YN, Dozois EJ, Boardman LA et al. Young-onset rectal cancer: Presentation, pattern of care and longtermoncologicoutcomescomparedtoamatchedolderonset cohort. Ann Surg Oncol 2011;18: 2469-2476.
26. Yeo SA, Chew MH, Koh PK et al. Young colorectal carcinoma patients do not have a poorer prognosis: A comparative review of 2,426 cases. Tech Coloproctol 2013;17: 653-661.
27. GoéréD,Deshaies I, de Baere T et al. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg 2010;251: 686-691.
28. Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 2004;240: 644-657; discussion 657-658.
29. Kouri M, Nordling S, Kuusela P et al. Poor prognosis associated with elevated serum CA 19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF. Eur J Cancer 1993;29A: 1691-1696.
30. Ishizuka D, Shirai Y, Sakai Y et al. Colorectal carcinoma liver metastases: Clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels. Int J Colorectal Dis 2001;16: 32-37.
31. Beppu T, Sakamoto Y, Hasegawa K et al. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2012;19: 72-84.